NCT05807087

Brief Summary

It is well-known and universally acknowledged that rhinoplasty is the most demanding procedure in facial aesthetic surgery. Postoperatively nasal osteotomies result in variable degrees of edema and ecchymosis and surgeons have tried various techniques, instruments, and postoperative methods to diminish these uncomfortable morbidities. Piezosurgery is used nowadays to decrease the incidence of injured soft tissues and vital structures passing near the osteotomy line. Its use in rhinoplasty was advocated to prevent unwanted back fractures as well as to decrease bleeding while keeping the nasal mucosa intact thus minimizing postoperative sequelae.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 16, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 16, 2022

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

March 15, 2023

Completed
27 days until next milestone

First Posted

Study publicly available on registry

April 11, 2023

Completed
Last Updated

April 11, 2023

Status Verified

March 1, 2023

Enrollment Period

1.1 years

First QC Date

March 15, 2023

Last Update Submit

March 28, 2023

Conditions

Outcome Measures

Primary Outcomes (4)

  • Operative time

    Operation duration will be calculated

    During procedure

  • Visual analogue score

    The VAS consists of a 10cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be')

    immediately after procedure

  • Change in periorbital edema

    Grade 1 - No coverage of iris with eyelids, Grade 2 - Slight coverage of iris with swollen eyelids, Grade 3 - Full coverage of iris with swollen eyelids, Grade 4 - Full closure of eyes.

    Baseline and 1 week

  • Change in eccyhmosis

    Grade 1 - Eccyhmosis upto the medial one-third part of lower and /or upper eyelid, Grade 2 - Ecchymosis upto the medial two-third part of the lower and/or upper eyelid. Grade 3 - Ecchymosis up to the full length and /or upper eyelid.

    Baseline and 1 week

Secondary Outcomes (1)

  • Functional - aesthetic outcome

    immediately after procedure

Study Arms (2)

Mechanical Osteotomy

ACTIVE COMPARATOR
Procedure: Conventional osteotomy

Piezosurgery

EXPERIMENTAL
Procedure: Piezosurgery osteotomy

Interventions

The nasal skeleton was accessed using a closed approach or an open approach is done via a transcolumellar and infracartilaginous incision. Osteotomy was made using osteotomes.

Mechanical Osteotomy

full exposure of the nasal bony pyramid is needed.

Piezosurgery

Eligibility Criteria

Age16 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Patients requesting aesthetic rhinoplasty, post-traumatic rhinoplasty, and post-cleft nose rhinoplasty.

You may not qualify if:

  • Patients with severe systemic disease (American Society of Anesthesiologists physical status classification system III \& IV).
  • Psychological disorders.
  • Female patients younger than 16 years of age and male patients younger than 18 years of age.
  • Patients with autoimmune and skin diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Outpatient Clinic of Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Alexandria University, Egypt

Alexandria, Azarita, 00203, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant lecturer of DPH and Clinical statistician

Study Record Dates

First Submitted

March 15, 2023

First Posted

April 11, 2023

Study Start

August 1, 2021

Primary Completion

September 16, 2022

Study Completion

September 16, 2022

Last Updated

April 11, 2023

Record last verified: 2023-03

Locations